Insufficient endogenous control of tumor necrosis factor-α contributes to temporomandibular joint pain and tissue destruction in rheumatoid arthritis

被引:0
|
作者
Alstergren, Per [1 ]
Kopp, Sigvard [1 ]
机构
[1] Karolinska Inst, Inst Odontol, Huddinge, Sweden
关键词
arthritis; cytokine receptors; rheumatoid arthritis; temporomandibular joint; tumor necrosis factor-alpha;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate whether pain and tissue destruction in the temporomandibular joint (TMJ) of patients with rheumatoid arthritis (RA) are influenced by plasma levels of the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) or the soluble receptor TNFsRII. Methods. Fifty-one patients with RA were included. TMJ resting pain intensity, pain intensity upon mandibular movement, tenderness to palpation, pressure-pain threshold,and presence of anterior open bite were assessed. Venous blood was obtained for analysis of TNF-alpha, TNFsRII, and inflammatory markers. Results. A total of 29 patients had TMJ pain and 22 patients had anterior open bite. In the group of patients with TMJ pain, 12 had anterior open bite and 17 did not. In the patients without TMJ pain 10 patients had anterior open bite and 12 did not. Patients with or without anterior open bite did not differ regarding any investigated variable. Plasma TNF-alpha and TNFsRII were positively correlated in the total patient sample. TNFsRII was negatively correlated with degree of anterior open bite in patients with TMJ pain but positively correlated with TMJ pressure-pain threshold in patients with elevated plasma TNF-alpha. Conclusion. Our results indicate that insufficient systemic endogenous control of TNF-alpha seems to contribute to TMJ pain and tissue destruction in RA.
引用
收藏
页码:1734 / 1739
页数:6
相关论文
共 50 条
  • [41] Lack of association of-863C/A (rs1800630) polymorphism of tumor necrosis factor-α gene with rheumatoid arthritis
    Sadaf, Tayyaba
    John, Peter
    Bhatti, Attya
    Malik, Javaid M.
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (02) : 531 - 536
  • [42] Anti-tumor necrosis factor-α therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis
    Uguz, Faruk
    Akman, Cemal
    Kucuksarac, Seher
    Tufekci, Osman
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 63 (01) : 50 - 55
  • [43] Effect of temporomandibular joint arthrocentesis on synovial fluid mediator level of tumor necrosis factor-α:: implications for treatment outcome
    Emshoff, R
    Puffer, P
    Strobl, H
    Gassner, R
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2000, 29 (03) : 176 - 182
  • [44] The-308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients
    Aranda, Federico
    Peres Wingeyer, Silvia D.
    Schneeberger, Emilce
    Valerio, Maria
    Saint Martin, Emilia
    Dal Pra, Fernando
    de los Angeles Correa, Maria
    Citera, Gustavo
    Martinez, Liliana
    Mannucci, Pablo
    Remondino, Graciela
    de Larranaga, Gabriela F.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (05) : 476 - 481
  • [45] Tumor necrosis factor-α and matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue is inhibited by blocking gap junction communication
    Nanke, Yuki
    Kobashigawa, Tsuyoshi
    Yago, Toru
    Kawamoto, Manabu
    Yamanaka, Hisashi
    Kotake, Shigeru
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 37 (03) : 237 - 242
  • [46] Association of tumor necrosis factor–α (G-308A) genetic variant with matrix metalloproteinase–9 activity and joint destruction in early rheumatoid arthritis
    Sonja Stojanovic
    Tatjana Jevtovic Bojana Stamenkovic
    Jovan Stoimenov
    Valentina Nedovic
    Milena Zivkovic
    Dusica Despotovic
    Clinical Rheumatology, 2017, 36 : 1479 - 1485
  • [47] Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-α therapy
    Kaur, PP
    Derk, CT
    Chatterji, M
    Dehoratius, RJ
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (08) : 1663 - 1665
  • [48] Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
    Maeki-Petaejae, Kaisa M.
    Elkhawad, Maysoon
    Cheriyan, Joseph
    Joshi, Francis R.
    Oestoer, Andrew J. K.
    Hall, Frances C.
    Rudd, James H. F.
    Wilkinson, Ian B.
    CIRCULATION, 2012, 126 (21) : 2473 - 2480
  • [49] Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs
    Bao-Anh Nguyen-Khoa
    Goehring, Earl L., Jr.
    Alexander, Kimberly A.
    Dong, Wei
    Napalkov, Pavel
    Jones, Judith K.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 42 (02) : 119 - 126
  • [50] Current tumor necrosis factor-α inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis
    Liang, GC
    Cordero, M
    Dyer, A
    Chang, RW
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (09) : 1662 - 1665